Isomeric fatty acids and tumorigenesis: a commentary on recent work

Area of Science:

• Nutritional Biochemistry
• Oncology
• Dietary Fat Research

Background:

• Trans fatty acids (TFAs) are unsaturated fats with a high degree of industrial production.
• Concerns exist regarding the potential role of TFAs in chronic diseases, including cancer.
• Existing literature on TFAs and tumorigenesis is limited but warrants critical review.

Purpose of the Study:

• To critically review the current scientific literature on the association between trans fatty acid intake and cancer development (tumorigenesis).
• To evaluate experimental and epidemiological evidence regarding the role of TFAs in promoting tumor growth and development.

Main Methods:

• Review of epidemiological studies investigating TFA intake and cancer incidence.
• Analysis of experimental studies in animal models (rats and mice) examining the effects of high-trans fat diets on induced or implanted tumors.
• Comparison of tumor promotion and metastasis in animals fed high-trans fat versus high-cis fat diets.

Main Results:

• No epidemiological or experimental studies to date demonstrate a valid association between TFA ingestion and tumorigenesis.
• A high-trans fat diet did not promote mammary tumor development in rats more than a high-cis fat diet.
• High-trans fat diets were found to be less tumor-promoting than a typical US diet fat blend and did not affect mammary tumor growth or metastasis in mice.
• Studies on induced colon tumors in rats showed no significant difference between diets high in cis or trans fatty acids.

Conclusions:

• Current evidence suggests that trans fatty acids are not uniquely related to tumor development.
• The reviewed studies consistently indicate a lack of a specific link between trans fatty acid consumption and increased cancer risk.
• Further research may be needed, but existing data do not support TFAs as a distinct driver of tumorigenesis.